The store will not work correctly when cookies are disabled.
1-Methyl-4-(3-phenyl-propyl)-piperazine
ID: ALA351230
PubChem CID: 12563600
Max Phase: Preclinical
Molecular Formula: C14H22N2
Molecular Weight: 218.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(CCCc2ccccc2)CC1
Standard InChI: InChI=1S/C14H22N2/c1-15-10-12-16(13-11-15)9-5-8-14-6-3-2-4-7-14/h2-4,6-7H,5,8-13H2,1H3
Standard InChI Key: VDMPTTZAUYEXDG-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
-1.0500 -0.1417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1500 -0.1500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1583 -0.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1458 0.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7500 -0.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7458 0.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6500 -0.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8458 0.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7500 -0.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9500 0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5500 0.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4458 0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5458 1.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7375 1.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8375 1.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4333 1.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 5 1 0
4 6 1 0
5 1 1 0
6 1 1 0
7 1 1 0
8 11 1 0
9 2 1 0
10 7 1 0
11 10 1 0
12 8 2 0
13 8 1 0
14 12 1 0
15 13 2 0
16 15 1 0
3 2 1 0
14 16 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 218.34 | Molecular Weight (Monoisotopic): 218.1783 | AlogP: 1.87 | #Rotatable Bonds: 4 |
Polar Surface Area: 6.48 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.45 | CX LogP: 2.49 | CX LogD: 1.41 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.76 | Np Likeness Score: -1.06 |
References
1. Glennon RA, Salley JJ, Steinsland OS, Nelson S.. (1981) Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists., 24 (6): [PMID:7252977] [10.1021/jm00138a007] |